Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Announces Appointment Of New CFO


Tuesday, 27 Nov 2012 05:26am EST 

Dr.Reddy's Laboratories Ltd announced that Umang Vohra who was CFO (Chief Financial Officer) will take over the role of the Executive Vice-President and Head of North America Generics Business from January 2013 and Saumen Chakraborty has been appointed as the CFO of the Company effective January 2, 2013. 

Company Quote

3054.35
16.3 +0.54%
23 Oct 2014